CLASS I Drug recall · Reported 1 Feb 2023 · FDA Enforcement Report

Epinephrine (L-Adrenaline), USP, CAS 51-43-4 amber recalled

Spectrum Laboratory Products is recalling Epinephrine (L-Adrenaline), USP, CAS 51-43-4 amber in a, distributed nationwide in the US. The recall was initiated on 19 Dec 2022 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot # 1KG0865 EXP 31-Mar-2023
Quantity recalled1 bottle

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0179-2023
FDA event ID
91381
Recalling firm
Spectrum Laboratory Products, New Brunswick, NJ
Classification
Class I
Status
Terminated
Recall initiated
19 Dec 2022
FDA classified
25 Jan 2023
Reported
1 Feb 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

19 Dec 2022Recall initiated by company
25 Jan 2023Classified by FDA+37 days
1 Feb 2023Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Epinephrine (L-Adrenaline), USP, CAS 51-43-4, 1 KG amber glass bottle in a vacuum sealed pouch, Rx only, Repackaged by Spectrum Chemical Mfg. Corp. Gardena, CA 90248; New Brunswick, NJ 08901. Product Code EP130

Where it was distributed

Nationwide in the USA, Puerto Rico and Canada

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product

Which lots are affected?

Lot # 1KG0865 EXP 31-Mar-2023

Where was it sold?

Nationwide in the USA, Puerto Rico and Canada

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 91381
ReportedClassRecallCompanyReasonWhere
CLASS IEpinephrine (L-Adrenaline), USP, CAS recalledSpectrum Laboratory ProductsPackaging DefectsNationwide

More recalls from Spectrum Laboratory Products

All 9

Other Epinephrine (l-adrenaline recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IEpinephrine (L-Adrenaline), USP, CAS recalledSpectrum Laboratory ProductsPackaging DefectsNationwide